Results 301 to 310 of about 454,057 (403)

Postprandial triglyceride levels affecting postprandial thyroid stimulating hormone levels may be responsible for the increased postprandial thyroid stimulating hormone levels in people with reduced lipid tolerance. [PDF]

Front Endocrinol (Lausanne)
Tian P, Zeng S, Hou Y, Liu D, Lu Y, Song G.   +5 more
europepmc   +1 more source

Identifying Failure Predictors in Thyroid Nodule Radiofrequency Ablation Using Multivariate Analysis: A Single‐Centre Experience

Clinical Endocrinology, EarlyView.
ABSTRACT Background Radiofrequency ablation (RFA) has become an established minimally invasive treatment for benign thyroid nodules (BTN), offering excellent safety and efficacy. However, factors predicting treatment success and post‐procedural thyroid dysfunction remain incompletely understood.
Shmuel Wechsler, Tanya Shcherbaeva, Jacob Pitaro, Limor Muallem Kalmovich   +3 more
wiley   +1 more source

The association of thyroid stimulating hormone and body fat in adults. [PDF]

PLoS One
Sun Q, He Y, Yang L.
europepmc   +1 more source

Comparative Analysis of Incidental and Non‐Incidental Papillary Thyroid Microcarcinoma Outcomes: Implications on Management Recommendations

Clinical Endocrinology, EarlyView.
ABSTRACT Introduction Papillary thyroid microcarcinomas (PTMC) are defined by the World Health Organisation (WHO) as tumours measuring ≤ 10 mm. Incidental PTMCs, or lesions discovered postoperatively on histological examination, are less extensively studied compared with lesions diagnosed preoperatively through cytology, particularly in terms of ...
Emma A. Finnegan, Justin M. Hintze, Anne McGowan, James Gibney, Conall W. R. Fitzgerald, John Kinsella, Marie Louise Healy   +6 more
wiley   +1 more source

The Free Thyroxine-to-Thyroid Stimulating Hormone Ratio: A Potential Diagnostic Marker for Graves' Disease. [PDF]

Int J Endocrinol Metab
Binti Rahmat N, Tuan Ismail TS, Bin Md Muslim MZ, Bin Wan Zain WMS, Bin Zakaria AZ, Bin Yusoff MY.   +5 more
europepmc   +1 more source

Responses of the Normal Human to Infusions of Plasma from Patients with Graves\u27 Disease [PDF]

, 1965
Arnaud, Claude D., Engbring, Norman H., Kneubuhler, Hans A., Seiling, Virginia L., Wightman, Bruce K.   +4 more
core   +1 more source

Thyroid-Stimulating Hormone-Secreting Pituitary Adenoma: Two Cases With Challenging Diagnosis and Management. [PDF]

Case Rep Endocrinol
Gruneisen E, Rivera JA.
europepmc   +1 more source

Adrenocorticotrophin and Adrenal Protein Synthesis [PDF]

, 1965
Reddy, W. J., Scriba, Peter Christian
core  

ACTH suppression and adverse effects of cabergoline in horses with pituitary pars intermedia dysfunction

Equine Veterinary Education, EarlyView.
Summary Background The diagnosis and management of pituitary pars intermedia dysfunction (PPID) in horses includes evaluating abnormal plasma concentrations of adrenocorticotrophic hormone (ACTH). Treatment commonly includes the oral dopamine agonist pergolide mesylate, which suppresses the pathologic overproduction of ACTH.
A. Bracken, H. Tyra, M. Vetter, K. Kiger, S. Rao, L. Bass   +5 more
wiley   +1 more source

Thyroid Stimulating Hormone May Facilitates Adipose Tissue Insulin Resistance by Inducing M1 Macrophage Polarization. [PDF]

J Inflamm Res
Fu M, Wang H, Zhang Y, Yang L, Chen Y, Chen X, Wang Z, Sun H.   +7 more
europepmc   +1 more source